IISc’s Foundation for Science, Innovation and Development has appointed Omprakash Subbarao as its chief executive officer and set a target of building a portfolio of 300 deep science and DeepTech startups by 2030. The move places a full-time industry professional at the head of an institution created to connect research at the Indian Institute of Science with commercial applications.
The appointment is more than a change in personnel. It places the question of technology translation at the centre of FSID’s next phase: whether research generated within an academic institution can be converted into companies, products and industry partnerships at a substantially larger scale. FSID currently has more than 140 startups in its ecosystem. Its stated 2030 targets include 300 startups, roughly twice as many research and industry projects, and a doubling in the number of companies with which it engages.
Subbarao, an IISc alumnus and former chief executive of FSID’s CORE Labs, is taking over as CEO. IISc professor Suryasarthy Bose has been appointed Professor-in-Charge, providing institutional oversight and strengthening the link between FSID and the institute. The leadership arrangement separates day-to-day industry-facing management from the academic institution’s oversight role.
That distinction is significant for an organisation whose stated purpose sits between research and business. FSID is a Section 8 company promoted by IISc and operates as a platform for deep science and DeepTech ventures. Its work involves research and industry projects, company engagements and the development of startups based on scientific and technological research. The new structure is intended to bring greater industry orientation, strengthen partnerships and increase the pace at which research is moved towards commercial use, according to the information reported by Deccan Herald.
The scale of the proposed expansion can be seen in FSID’s existing numbers. The organisation’s ecosystem includes more than 140 startups with a combined valuation of nearly $700 million, according to the report. FSID has made full exits from two companies: Strand Life Sciences, which operates in life sciences, and Mymo Wireless, which operates in communications. It has made partial exits from three other companies while continuing to hold equity in them.
These figures describe an organisation that already has an operating portfolio rather than a purely academic incubation programme. At the same time, the numbers also show the distance between the current position and the 2030 ambition. Reaching 300 startups would require FSID to add more than 150 companies to its portfolio or ecosystem, depending on how the target is ultimately defined and measured. The source material does not specify whether the figure refers to new incorporations, active companies, supported ventures or the total number of startups associated with the platform.
That measurement question matters because startup counts alone do not explain whether a research-commercialisation system is working. FSID’s reported exits provide evidence of some companies progressing beyond the incubation stage, but the available information does not establish the revenue, employment, product adoption or long-term performance of those businesses. Nor does it specify how many of the more than 140 startups are currently active, how much funding they have raised or how many technologies originated directly from IISc research.
FSID’s other targets indicate that the organisation wants to expand not only its startup portfolio but also the wider network around it. It aims to increase the number of research and industry projects it handles from more than 1,600 to about 3,200 by 2030. The number of companies it engages with is expected to rise from around 500 to 1,000. In effect, the stated plan is to double two major activity measures while more than doubling the startup portfolio.
The targets point to a model in which commercialisation is not limited to creating new companies. Research and industry projects can connect academic expertise with established businesses, while company engagements can include a broader set of relationships than startup incubation alone. The source does not provide a breakdown of these projects or engagements, so it is not possible to determine how they are distributed across sectors, technologies or stages of development. It is also not clear how FSID will assess the quality or outcomes of the expanded activity.
Subbarao’s appointment reflects the tension between academic timeframes and commercial decision-making. Explaining the rationale for the leadership change, he said that the technology and business environment was moving faster than the traditional academic cycle. “Earlier, companies operated quarter by quarter, but it is no longer even quarter by quarter. It is day by day, and with AI, it is probably minute by minute,” he said.
The statement identifies speed as a central institutional challenge. Academic research is generally organised around investigation, validation and publication, while companies must make decisions about product development, partnerships and markets under changing conditions. A research institution seeking to create businesses therefore has to operate across both systems. The appointment of an industry professional as CEO appears intended to strengthen the commercial and operational side of that interface without removing academic oversight.
The arrangement also raises a governance question. FSID’s connection to IISc gives it access to an academic research base and institutional credibility, while its Section 8 structure provides a separate organisational vehicle for its activities. The appointment of a professor as Professor-in-Charge suggests that the institute intends to retain a formal link with the platform as its external partnerships and company portfolio grow. However, the supplied information does not detail the decision-making powers of the CEO, the Professor-in-Charge or IISc, nor does it describe how conflicts between academic priorities and commercial interests will be managed.
The Bengaluru context is central to the story because FSID is part of the city’s research and technology ecosystem. Its expansion could increase the number of connections between IISc researchers, startups and companies, but the available material does not establish how the benefits will be distributed across the city or the wider country. FSID says its goal includes scaling its impact at national and international levels, yet the report does not identify specific locations, sectors or international partnerships involved in that plan.
Subbarao’s previous experience is also presented as part of the organisation’s rationale. He said his experience of taking Aadhaar from a pilot to large-scale implementation would inform FSID’s approach to technology translation. The source provides no further detail on the responsibilities he held in that process or on which aspects of that experience will be applied to research commercialisation. The significance of the reference therefore lies in the stated emphasis on moving technologies from an initial stage towards larger-scale implementation.
The numbers announced by FSID establish the ambition of the plan, but they do not yet establish its feasibility. The organisation will need to expand its startup and corporate networks while maintaining research links and managing an equity portfolio. It will also need to define how it counts startups, projects and company engagements. Without those definitions, future comparisons may show activity growth without showing whether the underlying commercial and research outcomes have improved.
The appointment consequently marks a shift in operating emphasis rather than proof of a completed transformation. FSID is moving from a platform with more than 140 startups and over 1,600 research and industry projects towards a stated 2030 model with 300 startups, about 3,200 projects and 1,000 company engagements. The next evidence will come from how those targets are translated into annual milestones, how the leadership structure functions in practice and whether the organisation can demonstrate outcomes beyond portfolio size.
For Bengaluru’s research-commercialisation system, the central issue is whether institutional science can be made more responsive to industry without weakening the research relationships on which it depends. FSID’s new leadership structure is designed to address that challenge. What remains uncertain is how the organisation will measure technology translation, how it will balance speed with scientific validation, and whether its expanded activity will produce durable companies and applications. Those will be the indicators to watch as the 2030 targets move from announcement to implementation.
